OrthoPediatrics Corp. (KIDS) Business Metric Overview - Stocknear

OrthoPediatrics Corp.

NASDAQ: KIDS · Real-Time Price · USD
18.28
0.26 (1.44%)
At close: Sep 26, 2025, 3:59 PM
18.28
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

OrthoPediatrics Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Dec 31, 2020 Dec 31, 2019 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017
Spine Revenue 18.52M 13.66M 29.32M 15.63M 13.68M 10.2M 9.66M 10.3M 10.89M 7.07M 8.04M 9.98M 9.42M 5.98M 7.17M 7.27M 7.66M 6.64M 4.89M 4.9M 2.69M 8.29M 3.3M
Spine Revenue Growth +35.55% -53.39% +87.50% +14.27% +34.10% +5.58% -6.21% -5.41% +54.03% -12.09% -19.38% +5.92% +57.46% -16.58% -1.29% -5.11% +15.39% +35.68% -0.12% +82.38% -67.60% +151.17% n/a
Sports Medicine And Other Revenue 905K 880K n/a 1.3M 1.35M 1.18M n/a 862K 1.15M 1.12M n/a 1.08M 939K 918K n/a 996K 1.1M n/a n/a n/a n/a n/a n/a
Sports Medicine And Other Revenue Growth +2.84% n/a n/a -3.93% +14.32% n/a n/a -25.17% +2.77% n/a n/a +14.91% +2.29% n/a n/a -9.86% n/a n/a n/a n/a n/a n/a n/a
Trauma And Deformity Revenue 41.66M 37.87M n/a 37.64M 37.77M 33.3M n/a 28.81M 27.51M 23.39M n/a 23.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Trauma And Deformity Revenue Growth +10.00% n/a n/a -0.34% +13.42% n/a n/a +4.70% +17.61% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017
Non-Us Revenue 12.94M 11.52M 21.32M 11.86M 11.55M 10.38M 9.35M 10.61M 9.97M 7.79M 8.26M 8.41M 7.97M 5.23M 5.72M 4.96M 4.62M 2.62M 1.45M 2.97M 3.96M 4.35M 4.39M 3.64M 3.4M 3.62M 3.44M 7.89M 2.82M
Non-Us Revenue Growth +12.28% -45.98% +79.82% +2.65% +11.30% +11.02% -11.89% +6.42% +28.04% -5.74% -1.77% +5.56% +52.38% -8.66% +15.47% +7.25% +76.32% +81.20% -51.31% -24.93% -9.03% -0.84% +20.61% +7.06% -6.08% +5.17% -56.40% +179.96% n/a
United States Revenue 48.15M 40.89M 84.14M 42.71M 41.25M 34.3M 28.26M 29.36M 29.59M 23.8M 22.73M 26.54M 24.96M 18.19M 19.35M 21.74M 16.84M 19.58M 12.15M 13.38M 16.79M 13.85M 10.27M 10.93M 12.42M 11.46M 8.65M 25.35M 9.56M
United States Revenue Growth +17.74% -51.40% +96.99% +3.55% +20.24% +21.38% -3.74% -0.77% +24.32% +4.70% -14.34% +6.33% +37.23% -6.02% -10.96% +29.09% -14.01% +61.23% -9.25% -20.26% +21.21% +34.88% -6.06% -12.01% +8.40% +32.42% -65.87% +165.31% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Mar 31, 2015
Selling, General, and Administrative Revenue 49.55M 46.85M 41.22M 43.05M 43.92M 38.9M 32.03M 32.09M 32.82M 29.88M 27.5M 27.04M 26.98M 22.93M 22.03M 20.9M 21.96M 20.99M 19.47M 19.06M 16.2M 15.45M 15.58M 16.04M 14.18M 12.16M 11.1M 12.03M 12.28M 12.1M 12.1M 9.12M 8.72M 7.57M 9.03M 7.18M 7.1M 6.96M 5.78M
Selling, General, and Administrative Revenue Growth +5.75% +13.68% -4.26% -1.99% +12.91% +21.43% -0.17% -2.22% +9.83% +8.67% +1.72% +0.21% +17.68% +4.04% +5.45% -4.86% +4.64% +7.81% +2.15% +17.68% +4.87% -0.84% -2.88% +13.14% +16.58% +9.51% -7.68% -2.02% +1.48% +0.01% +32.62% +4.58% +15.28% -16.21% +25.76% +1.08% +2.00% +20.49% n/a
Research and Development Revenue 2.16M 2.35M 2.92M 2.58M 2.54M 3M 2.75M 2.39M 2.79M 2.27M 2.03M 2.21M 1.75M 2.03M 1.61M 1.3M 1.32M 1.31M 2.05M 1.08M 881K 1.26M 1.91M 1.4M 1.23M 1.21M 1.28M 1.12M 1.11M 1.22M 941K 1.13M 668K 687K 624K 501K 589K 507K 479K
Research and Development Revenue Growth -8.17% -19.38% +13.15% +1.34% -15.18% +9.14% +15.08% -14.51% +23.00% +11.60% -7.80% +26.27% -13.81% +26.06% +23.50% -1.74% +1.30% -36.20% +90.34% +22.25% -30.36% -33.60% +36.46% +13.13% +1.73% -5.01% +13.81% +0.63% -8.46% +29.44% -16.50% +68.71% -2.77% +10.10% +24.55% -14.94% +16.17% +5.85% n/a
Sales and Marketing Revenue 19.1M 16.57M 16.78M 16.75M 16.59M 14.17M 12.44M 13.94M 13.16M 12.22M 10.95M 11.92M 12.43M 9.76M 9.99M 9.86M 10.88M 8.95M 9.43M 9.24M 5.62M 7.56M 8.36M 8.77M 7.61M 6.55M 6.56M 7.15M 6.78M 6.08M 5.41M 5.63M 5.3M 4.19M 4.26M 4.29M 4.34M 3.77M 3.21M
Sales and Marketing Revenue Growth +15.27% -1.26% +0.20% +0.95% +17.11% +13.91% -10.78% +5.90% +7.77% +11.61% -8.17% -4.12% +27.39% -2.28% +1.26% -9.32% +21.53% -5.13% +2.12% +64.36% -25.70% -9.52% -4.69% +15.32% +16.18% -0.17% -8.28% +5.52% +11.47% +12.47% -4.05% +6.30% +26.41% -1.60% -0.68% -1.08% +15.01% +17.56% n/a